Palm Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Cancelled)

  • Investors
  • 8

Palm Therapeutics General Information

Description

Provider of biotechnology research services intended for therapeutics to treat cancer. The company has developed its proprietary technology to create small molecule DE palmitoylating drugs (DPALMs) and developed DPALM-based inhibitors for HRas and NRas, oncogenic targets that can be used to cleave palmitoyl groups from target proteins to inhibit their function, enabling clients to treat HNSCC, AML, and bladder cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3210 Merryfield Row
  • San Diego, CA 92121
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 3210 Merryfield Row
  • San Diego, CA 92121
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Palm Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 14-Feb-2024 Cancelled Startup
8. Accelerator/Incubator 03-Apr-2024 Completed Startup
7. Later Stage VC 31-Jan-2024 Completed Startup
6. Grant 15-Mar-2022 Completed Startup
5. Grant 30-Aug-2021 Completed Startup
4. Accelerator/Incubator Completed Startup
3. Accelerator/Incubator 01-Jan-2021 Completed Startup
2. Grant 23-Nov-2020 $524K Completed Startup
1. University Spin-Out 01-Jan-2018 Completed Startup
To view Palm Therapeutics’s complete valuation and funding history, request access »

Palm Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Palm Therapeutics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
CONNECT (San Diego) Accelerator/Incubator
SeedFolio Venture Capital Minority
Tachyon Ventures Venture Capital Minority
National Institutes of Neurological Disorders and Stroke Government
Creative Destruction Lab Accelerator/Incubator
You’re viewing 5 of 8 investors. Get the full list »

Palm Therapeutics FAQs

  • When was Palm Therapeutics founded?

    Palm Therapeutics was founded in 2018.

  • Where is Palm Therapeutics headquartered?

    Palm Therapeutics is headquartered in San Diego, CA.

  • What is the size of Palm Therapeutics?

    Palm Therapeutics has 5 total employees.

  • What industry is Palm Therapeutics in?

    Palm Therapeutics’s primary industry is Drug Discovery.

  • Is Palm Therapeutics a private or public company?

    Palm Therapeutics is a Private company.

  • What is the current valuation of Palm Therapeutics?

    The current valuation of Palm Therapeutics is .

  • What is Palm Therapeutics’s current revenue?

    The current revenue for Palm Therapeutics is .

  • Who are Palm Therapeutics’s investors?

    CONNECT (San Diego), SeedFolio, Tachyon Ventures, National Institutes of Neurological Disorders and Stroke, and Creative Destruction Lab are 5 of 8 investors who have invested in Palm Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process